U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

1997
189
Name Type Language
RITUXIMAB (GENETICAL RECOMBINATION)
JAN  
Preferred Name English
RITUXIMAB
EMA EPAR   HSDB   INN   MART.   MI   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
IDEC-C 2B8
Code English
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Common Name English
RITUXIMAB [HSDB]
Common Name English
Rituximab [WHO-DD]
Common Name English
RITUXIMAB [MART.]
Common Name English
RITUXIMAB [MI]
Common Name English
GP2013
Code English
IDEC-102
Code English
RITUXAN HYCELA COMPONENT RITUXIMAB
Brand Name English
RITUXIMAB [USAN]
Common Name English
RITUXIMAB [EMA EPAR]
Common Name English
USP MAB 001, MONOCLONAL IGG1 [USP-RS]
Common Name English
RITUXIMAB [VANDF]
Common Name English
rituximab [INN]
Common Name English
GP-2013
Code English
RITUXIMAB [JAN]
Common Name English
RITUXIMAB [PURPLE BOOK CDER]
Common Name English
IDEC102
Code English
Classification Tree Code System Code
EMA ASSESSMENT REPORTS MABTHERA (AUTHORIZED: ARTHRITIS, RHEUMATOID)
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
EMA ASSESSMENT REPORTS MABTHERA (AUTHORIZED: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL)
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
FDA ORPHAN DRUG 177603
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
FDA ORPHAN DRUG 923822
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
NDF-RT N0000175078
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
FDA ORPHAN DRUG 781520
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
FDA ORPHAN DRUG 465014
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
FDA ORPHAN DRUG 840621
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
FDA ORPHAN DRUG 542416
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
WHO-VATC QL01XC02
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
NCI_THESAURUS C129822
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
EMA ASSESSMENT REPORTS MABTHERA (AUTHORIZED: LYMPHOMA, NON-HODGKIN)
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
FDA ORPHAN DRUG 79793
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
FDA ORPHAN DRUG 546516
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
LIVERTOX NBK548249
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
FDA ORPHAN DRUG 922222
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
FDA ORPHAN DRUG 216305
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
NCI_THESAURUS C141215
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
NDF-RT N0000175657
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
FDA ORPHAN DRUG 155102
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
FDA ORPHAN DRUG 545616
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
WHO-ATC L01XC02
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
FDA ORPHAN DRUG 529816
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
EU-Orphan Drug EU/3/17/1869
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
Code System Code Type Description
IUPHAR
6780
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
PRIMARY
MERCK INDEX
m9637
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
PRIMARY Merck Index
SMS_ID
100000089292
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
PRIMARY
DRUG BANK
DB00073
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
PRIMARY
RXCUI
2273510
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
ALTERNATIVE
JAPANESE REVIEW
RITUXAN
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
PRIMARY APPROVED AUGUST 2014
DAILYMED
4F4X42SYQ6
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
PRIMARY
ChEMBL
CHEMBL1201576
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
PRIMARY
WIKIPEDIA
RITUXIMAB
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
PRIMARY
USAN
II-64
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
PRIMARY
RS_ITEM_NUM
1445539
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
PRIMARY
NCI_THESAURUS
C1702
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
PRIMARY
INN
7609
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
PRIMARY
CAS
174722-31-7
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
PRIMARY
RXCUI
121191
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
PRIMARY RxNorm
EVMPD
SUB12570MIG
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
PRIMARY
MESH
C092560
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
PRIMARY
LACTMED
Rituximab
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
PRIMARY
EPA CompTox
DTXSID5040910
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
PRIMARY
FDA UNII
4F4X42SYQ6
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
PRIMARY
RXCUI
2105824
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
ALTERNATIVE
DRUG CENTRAL
4975
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
PRIMARY
JAPANESE REVIEW
ROMIPLATE
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
PRIMARY APPROVED JANUARY 2011
HSDB
7455
Created by admin on Mon Mar 31 18:48:10 GMT 2025 , Edited by admin on Mon Mar 31 18:48:10 GMT 2025
PRIMARY
ACTIVE MOIETY
RITUXIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966